-
The global insurer will need to convince investors on the quality of the book. -
Dealmaking took centerstage, but other discussed topics were growth, talent and capacity.
-
There’s nothing medical about SAM claims.
-
MGAs that are good operators will stick out compared to the rest.
-
The mood in Orlando was sunny among cedants and reinsurers alike, but there are clouds on the horizon.
-
E&S is most exposed to growth normalization, private credit is hunting P&C and fronting is deadlocked on exits.
-
Insurers are pleased, brokers are looking for trade-offs, and everyone’s talking about Howden.
-
Sexual abuse and molestation exclusions are starting to hold in higher layers of hospital towers this year.
-
The as-yet unnamed platform will have to compete in a crowded market for M&A and lift-out opportunities.
-
Winners and losers will emerge more clearly, with less opportunity to ride the market wave.
-
The insurer has chosen a “take two” deal after buying Endurance, betting again on Bermuda.
-
The completion is also good news for Marsh, Aon, WTW and other potential buyers in US retail.
Most Recent
